Search
GSK plc
GSKAdd to Watchlist
52.500USD
+0.600+1.16%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
105.93BMarket Cap
13.53P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-26The current earnings forecast score of GSK plc is 7.20, ranking 107 out of 157 in the Pharmaceuticals industry. The average price target is 45.30, with a high of 56.23 and a low of 34.26.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
51.901
Target Price
+0.02%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
GSK plc
GSK
9
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is GSK plc's expected revenue for the next quarter?
GSK plc's expected revenue is 10.97B.
What is GSK plc's price target?
Analysts forecast that GSK plc's price target is USD 45.30, with the highest forecast at USD 56.23 and the lowest forecast at USD 34.26.
How have GSK plcGSK's recent earnings per share performed?
The market expectation was USD 1.16, while GSK plcGSK's earnings per share (EPS) for the previous quarter was USD 0.42. EPS for the next quarter is expected at USD 1.26.
What is the analyst rating for GSK plc?
Based on the ratings of GSK plc's stock from 9 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
